Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 1.00 |
| ▸ | MAOA | P21397 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2A6 | P11509 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | ACHE | P22303 | 1/20 | 1.00 |
| ▸ | PDE4A | P27815 | 1/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 1.00 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.69 |
| ▸ | POLB | P06746 | 2/20 | 0.69 |
| ▸ | MAPT | P10636 | 2/20 | 0.69 |
| ▸ | MAOB | P27338 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.62 |
| ▸ | HPGD | P15428 | 5/20 | 0.62 |
| ▸ | CA9 | Q16790 | 5/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methoxsalen SCHEMBL2302069 | 1.00 | CYP3A4 (1.00) | CYP3A4MAOACYP1A2CYP2A6MAPK1 | |
| Methoxsalen SCHEMBL29376525 | 1.00 | CYP3A4 (1.00) | CYP3A4MAOACYP1A2CYP2A6MAPK1 | |
| Methoxsalen SCHEMBL6142553 | 0.98 | CYP3A4 (0.97) | CYP3A4MAOACYP1A2CYP2A6MAPK1 | |
| Methoxsalen SCHEMBL9387169 | 0.93 | CYP3A4 (0.86) | CYP3A4MAOACYP1A2CYP2A6MAPK1 | |
| Methoxsalen SCHEMBL10572509 | 0.92 | CYP3A4 (0.84) | CYP3A4MAOACYP1A2CYP2A6MAPK1 | |
| Methoxsalen SCHEMBL598765 | 0.90 | CYP3A4 (0.82) | CYP3A4MAOACYP1A2CYP2A6MAPK1 | |
| Bergapten SCHEMBL9792363 | 0.86 | CYP3A4 (0.74) | CYP3A4MAOACYP1A2CYP2A6MAPK1 | |
| SCHEMBL7781220 | 0.84 | CYP3A4 (0.72) | CYP3A4MAOACYP1A2CYP2A6MAPK1 | |
| SCHEMBL18788583 | 0.83 | CYP3A4 (0.71) | CYP3A4MAOACYP1A2CYP2A6MAPK1 | |
| SCHEMBL13660657 | 0.83 | CYP3A4 (0.71) | CYP3A4MAOACYP1A2CYP2A6MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 21232 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4007582-B1 | ANTIBIOTICS IN COMBINATION WITH PHOTODYNAMIC THERAPY FOR USE IN A METHOD OF ENHANCING THE ANTIMICROBIAL ACTION OF SYSTEMICALLY ADMINISTERED ANTIBIOTICS | KOITE HEALTH OY (FI) | 2026-05-20 | — | — | EP | claimed |
| CN-122056865-A | Application of xanthotoxin in preparation of medicines for treating liver cancer | 蕲春县人民医院 | 2026-05-19 | — | — | CN | claimed |
| US-20260131003-A1 | Method and kit for treating skin infections | KOITE HEALTH OY (FI) | 2026-05-14 | — | — | US | claimed |
| EP-4255560-B1 | KIT FOR TREATMENT OF PATIENTS HAVING DRY MOUTH SYNDROME | KOITE HEALTH OY (FI) | 2026-04-22 | — | — | EP | claimed |
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECH INC (US) | 2026-04-09 | — | — | US | claimed |
| US-20260061057-A1 | METHOD FOR GENERATING IMMUNOREGULATORY CELLS IN A BLOOD-DERIVED SAMPLE | THERAKOS DEVELOPMENT LTD (IE) | 2026-03-05 | — | — | US | claimed |
| EP-4680203-A1 | COMPOSITIONS FOR SUSTAINED RELEASE OF POORLY SOLUBLE ACTIVE INGREDIENTS | Prolevi Bio AB (SE) | 2026-01-21 | — | — | EP | claimed |
| US-12521436-B2 | Method and kit for treating skin infections | KOITE HEALTH OY (FI) | 2026-01-13 | — | — | US | claimed |
| US-12509465-B2 | Benzoimidazole derivatives as anticancer agents | CENTRE LEON BERARD (FR) | 2025-12-30 | — | — | US | claimed |
| US-20250388642-A1 | COMPOSITIONS AND METHODS FOR IMPROVED NK CELL THERAPIES | CERUS CORPORATION (US) | 2025-12-25 | — | — | US | claimed |
| EP-0165313-A1 | NUCLEIC ACID HYBRIDIZATION ASSAY. | HYDROCARBON RESEARCH INC (US) | 1985-12-27 | — | — | EP | claimed |
| WO-1985002628-A1 | NUCLEIC ACID HYBRIDIZATION ASSAY | HRI RESEARCH, INC. (US) | 1985-06-20 | — | — | WO | claimed |
| EP-0138489-A1 | Apparatus and methods for treating cells with radiation | McNeilab, Inc. (US) | 1985-04-24 | — | — | EP | claimed |
| US-4454152-A | WITH POLYOXYETHYLENE GLYCOL, FOR ORAL ADMINISTRATION | HOFFMANN-LA ROCHE INC. (US) | 1984-06-12 | — | — | US | claimed |
| US-4321919-A | Method and system for externally treating human blood | LEUKOCYTE RESEARCH, INC. (US) | 1982-03-30 | — | — | US | claimed |
| EP-0039874-A2 | Methoxsalen compositions and their preparation | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-11-18 | — | — | EP | claimed |
| US-RE30376-E | 8-Methoxypsoralen | THOMAS C. ELDER, INC. (US) | 1980-08-19 | — | — | US | claimed |
| US-RE30377-E | Process for making ω-chloro-2,3,4-trihydroxyacetophenone | THOMAS C. ELDER, INC. (US) | 1980-08-19 | — | — | US | claimed |
| US-4129575-A | 8-Methoxypsoralen | THOMAS C. ELDER, INC. (US) | 1978-12-12 | — | — | US | claimed |
| US-4129576-A | Process for making ω-chloro-2,3,4-trihydroxyacetophenone | THOMAS C. ELDER, INC. (US) | 1978-12-12 | — | — | US | claimed |